Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Day One Biopharmaceuticals, Inc.

Clinical trials sponsored by Day One Biopharmaceuticals, Inc., explained in plain language.

Day One Biopharmaceuticals, Inc. DAWN NASDAQ

Develops targeted therapies for pediatric cancer patients.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Terminated 2

New pill may replace chemo for kids with brain tumors

Disease control Ongoing

This study tests a new drug called DAY101 (tovorafenib) against standard chemotherapy for children and young adults with a type of brain tumor called low-grade glioma that has a specific gene change (RAF alteration). The goal is to see if the new drug works better at shrinking tu…

Phase: PHASE3 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC